Clinical chemistry and clinical toxicology devices; classification of B-type natriuretic peptide test system. Food and Drug Administration, HHS. Final rule.
The Food and Drug Administration (FDA) is classifying the B-type natriuretic peptide (BNP) test system into class II (special controls). The special control that will apply to this device is a guidance document entitled "Class II Special Control Guidance Document for B-Type Natriuretic Peptide Premarket Notifications; Final Guidance for Industry and FDA Reviewers." The agency is taking this action in response to a petition submitted under the Federal Food, Drug, and Cosmetic Act (the act) as amended by the Medical Device Amendments of 1976, the Safe Medical Devices Act of 1990, and the Food and Drug Administration Modernization Act of 1997. The agency is classifying these devices into class II (special controls) in order to provide a reasonable assurance of the safety and effectiveness of the device.
D009320:Atrial Natriuretic Factor / Q000097:blood*; D018795:Device Approval / Q000331:legislation & jurisprudence; D006333:Heart Failure / Q000097:blood; D006801:Humans; D011933:Reagent Kits, Diagnostic / Q000145:classification*; D014481:United States; D014486:United States Food and Drug Administration
D011933:Reagent Kits, Diagnostic; D009320:Atrial Natriuretic Factor